Abstract
This case report describes the development of dependence to phenibut, a gamma-aminobutyric acid-receptor type B agonist, in a patient concurrently being treated with buprenorphine. The patient experienced withdrawal symptoms which were successfully treated with a phenobarbital taper based on a protocol to treat sedative use disorder. This case report provided an example of the development of a phenibut use disorder and also brought up a public health question of whether phenibut should therefore be officially classified and monitored.
Original language | English (US) |
---|---|
Pages (from-to) | 239-240 |
Number of pages | 2 |
Journal | Journal of addiction medicine |
Volume | 11 |
Issue number | 3 |
DOIs | |
State | Published - Jan 1 2017 |
Keywords
- designer drug
- phenibut
- phenobarbital